InsidersTradesSigma
Browse the complete record of transactions filed by Lloyd Ronald K., 董事长兼首席执行官. Insider active across 1 company, notably Aziyo Biologics, INC.. In total, 1 disclosures have been published. Activity tracked since 8 March 2022. The latest transaction was disclosed on 8 March 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Ronald K. Lloyd is the President and CEO of Aziyo Biologics, Inc. He is responsible for the strategic direction of the company, which specializes in developing biological solutions for regenerative medicine. Aziyo Biologics, Inc. is committed to improving patient outcomes through innovative technologies.